ITF Therapeutics Revenue
Pharmaceutical Manufacturing • 
Concord, Massachusetts, United States • 51-100 Employees
ITF Therapeutics revenue & valuation
| Annual revenue | $6,245,515 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $20,000,000 |
| Total funding | No funding |
Key Contacts at ITF Therapeutics
Katiana Gruppioni
Director, Evidence Generation
Scott Friedel
Regional Business Director
Valencia Greene Foster
Associate Director, Thought Leader Liaison
Christina Tumminello
Senior Director Business Operations
Beth Kinsella
Us, Head Of Sales
Victor Nazario
Associate Director, Northeast Thought Leader Liaison
Aaron Felix
Regional Business Director-Central Us
Melinda Baker
Director Of Marketing
Eric Iwahiro
Regional Business Director
Ally Leonard
Director, Medical Operations
Company overview
| Headquarters | Concord, Massachusetts, United States |
| Phone number | +18664838479 |
| Website | |
| NAICS | 3254 |
| Keywords | Life Sciences, Healthcare, Research, Clinical Research, Pharmaceuticals, Rare Diseases, Drug Development, Neuromuscular, Patient Advocacy, Clinical Development, Duchenne Muscular Dystrophy, Clinical Trial, DMD, Rare Disorders, Clinical Study, Duchenne, Neuromuscular Disease, Muscular Dystrophy |
| Founded | 2024 |
| Employees | 51-100 |
| Socials |
ITF Therapeutics Email Formats
ITF Therapeutics uses 3 email formats. The most common is {first name}.{last name} (e.g., john.doe@itftherapeutics.com), used 59.4% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@itftherapeutics.com | 59.4% |
{first initial}.{last name} | j.doe@itftherapeutics.com | 35.9% |
{last name}.{last name} | doe.doe@itftherapeutics.com | 4.7% |
About ITF Therapeutics
ITF Therapeutics is the US-based rare disease division of Italfarmaco S.p.A. Founded in 1938 in Milan, Italy, Italfarmaco is a private global pharmaceutical company that has led the successful development of many innovative therapeutic products approved for use by patients around the world. The company operates in more than 90 countries on five continents and continues to advance promising research to address unmet medical needs in a wide range of therapeutic areas. In January 2024, Italfarmaco launched ITF Therapeutics as a new division in the United States with a focus on the development and commercialization of products to treat rare diseases. Building on a legacy grounded in collaboration and innovation, ITF Therapeutics strives to partner with leaders from the US patient advocacy and treatment communities to ensure that our programs reflect and support their unique needs and goals. The establishment of ITF Therapeutics reflects Italfarmaco’s goal to build a world- class team of experts who share a passion to make a positive impact for rare disease communities.
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
ITF Therapeutics has 26 employees across 7 departments.
Departments
Number of employees
Funding Data
ITF Therapeutics has never raised funding before.
ITF Therapeutics Tech Stack
Discover the technologies and tools that power ITF Therapeutics's digital infrastructure, from frameworks to analytics platforms.
CDN
Web frameworks
CMS
Miscellaneous
JavaScript libraries
Advertising
Programming languages
Analytics
UI frameworks
Font scripts
Tag managers
Australia
Frequently asked questions
4.8
40,000 users
